HILLSIDE, N.J., July 25, 2008 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) today announced that it has established a record date and a distribution date with respect to the spin-off of the Company’s interest in iBioPharma, Inc. (formerly InB:Biotechnologies, Inc.) (“iBioPharma”), pro rata to all of INBP’s public stockholders (the “Spin-Off”). INBP has responded to all comments made by the U.S. Securities and Exchange Commission (“SEC”) to the Company’s Information Statement and Form 10 relating to the Spin-Off and has been notified by the SEC that there will be no further comments.
